RESEARCH-USE BIOSIMILAR ANTIBODY
Remternetug
Monoclonal antibody · Not specified
Remternetug (LY3372993) is a monoclonal antibody that targets pyroglutamylated amyloid β fibrils (N3pG-Aβ). Remternetug specifically binds to N3pG-Aβ, thereby clearing amyloid plaques in the brain and reducing amyloid burden. Remternetug can be used in research related to Alzheimer's disease.
TARGETAPP
YMonoclonal antibody
CATALOGSC-BS-226
CATALOG NUMBERSC-BS-226
MOLECULAR WEIGHTApprox. 144.916 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Remternetug (LY3372993) is a monoclonal antibody that targets pyroglutamylated amyloid β fibrils (N3pG-Aβ). Remternetug specifically binds to N3pG-Aβ, thereby clearing amyloid plaques in the brain and reducing amyloid burden. Remternetug can be used in research related to Alzheimer's disease.
Remternetug is a recombinant research-use antibody directed against APP.